Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAbu Dhabi Health Services Company
About this trial
A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age more than 18.
STEMI complicated by cardiogenic shock.
Were hospitalized or treated at SSMC or SKMC for STEMI complicated by cardiogenic shock.
Patient admitted between January 2019 to March 2024.
Disqualifiers
Age less than 18.
Shock patient not related to Myocardial infarction.
NSTEMI-related cardiogenic shock.
Patients who were not treated at SSMC or SKMC for the STEMI complicated by cardiogenic shock.
Trial population
Patients with STEMI complicated by cardiogenic shock on admission or after hospitalization were treated in Abu Dhabi city from January 2020 to January 2024.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
400 Participants
are grouped into 1 trial groupGroup A: Patients with STEMI & Cardiogenic Shock
Trial outcomes
Primary outcomes
1
Analyze STEMI patient with CS disease profile
Comorbidities, demographical information, past medical history, morbidity
Time frame
5 years2
Incidence of CS-complicated AMI events
The incidence of CS-complicated AMI events will show an increase over the years because of advanced diagnostic modalities and a clearer definition of CS.
Time frame
5 years3
Analyze treatment outcomes in the targeted population as per the patient profile
Incidence of Mortality
Time frame
5 years4
Analyze STEMI patient with CS disease profile
Incidence of Morbidity
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Abu Dhabi Health Services Company
Lead sponsor
Sheikh Shakhbout Medical City
Collaborator
Sheikh Khalifa Medical City
Collaborator
Source ClinicalTrials.gov